UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.
复制标题
DOI:
10.1016/j.cancergencyto.2009.08.018
复制
发表时间:
2010-01-01
影响因子:
--
通讯作者:
Linehan WM
中科院分区:
文献类型:
--
作者:
Yang Y;Valera VA;Padilla-Nash HM;Sourbier C;Vocke CD;Vira MA;Abu-Asab MS;Bratslavsky G;Tsokos M;Merino MJ;Pinto PA;Srinivasan R;Ried T;Neckers L;Linehan WM
Energy deregulation and abnormalities of tumor cell metabolism are critical issues in our understanding of cancer. Hereditary leiomyomatosis renal cell carcinoma (HLRCC) is an aggressive form of RCC characterized by germline mutation of the Krebs cycle enzyme, fumarate hydratase (FH), and is known to be highly metastatic and unusually lethal. There is significant utility in establishing preclinical cell and xenograft models for study of disorder of energy metabolism as well as development of new therapeutic approaches targeting of tricarboxylic acid (TCA) cycle deficient human cancers. Here we report the first immortal cell line derived from a patient having aggressive HLRCC-associated recurring kidney cancer, designated as UOK 262. We investigated gene expression, chromosome profiles, efflux bioenergetic analysis, mitochondrial ultrastructure, FH catabolic activity, invasiveness, and optimal glucose requirements for in vitro growth. UOK 262 cells have isochromosome 1q [i(1)(q10)] as recurring chromosome abnormality; demonstrate compromised oxidative phosphorylation and in vitro dependence on anaerobic glycolysis consistent with the clinical manifestation of HLRCC. Furthermore the cells display glucose-dependent growth, an elevated rate of lactate efflux, over-expression of the glucose transporter Glut 1 and lactate dehydrogenase (LDH) 5. Mutant FH protein was primarily present in edematous mitochondria, but its catalytic activity was nearly undetectable. UOK 262 xenografts retain the characteristics of HLRCC histopathology. Our findings indicate that the severe compromise of oxidative phosphorylation and rapid glycolytic flux in UOK 262 are an essential feature of this TCA cycle enzyme deficient form of kidney cancer. This tumor model is the embodiment of the “Warburg effect”. UOK 262 provides a unique in vitro and in vivo preclinical mode to study the bioenergetics of the Warburg effect in human cancer.
登录
查看更多内容
影响因子:
6
作者:
Kiuru, M;Launonen, V;Aaltonen, LA
通讯作者:
Aaltonen, LA
影响因子:
5.3
作者:
Sudarshan S;Sourbier C;Kong HS;Block K;Valera Romero VA;Yang Y;Galindo C;Mollapour M;Scroggins B;Goode N;Lee MJ;Gourlay CW;Trepel J;Linehan WM;Neckers L
通讯作者:
Neckers L
影响因子:
5.6
作者:
Merino, Maria J.;Torres-Cabala, Carlos;Linehan, William Marston
通讯作者:
Linehan, William Marston
影响因子:
3.5
作者:
Alam, NA;Rowan, AJ;Tomlinson, IPM
通讯作者:
Tomlinson, IPM
影响因子:
2.3
作者:
Bowes, Timothy;Singh, Bhag;Gupta, Radhey S.
通讯作者:
Gupta, Radhey S.